Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Morepen Laboratories Ltd. Call Transcript 2023

Nov 3, 2023

59389_rns_2023-11-03_6515bdeb-8adb-4885-a97a-391dde073ab6.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [92 x 841] intentionally omitted <==

==> picture [48 x 74] intentionally omitted <==

==> picture [159 x 38] intentionally omitted <==

Date: 03.11.2023

National Stock Exchange of India Ltd.

BSE Limited

Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai- 400 051 Symbol: MOREPENLAB

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 500288

Subject: Audio recording of Earnings Conference Call

Reference: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)

Dear Sir/ Madam,

Pursuant to Regulation 30(6) read with Part A of Schedule III of the Listing Regulations, we wish to inform that the audio recording of Earnings Conference Call held on 3[rd] November 2023, on unaudited financial results for the quarter and half year ended September 30, 2023, is available on the company’s website at https://www.morepen.com/public/img/Q2_FY24_Concall_Audio.mp3.

Kindly take note of aforesaid into your records.

Thanking you,

Yours faithfully,

For Morepen Laboratories Limited

VIPUL Digitally signed KUMAR SRIVASTAV by VIPUL KUMAR SRIVASTAVA Date: 2023.11.03 A 20:22:47 +05'30'

Vipul Kumar Srivastava Company Secretary

Morepen Laboratories Limited

CIN NO. L24231 HP1984PLC006028

Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector-20, Gurugram, Haryana-122016, INDIA TEL.: +91 124 4892000, E-mail: [email protected], Website: www.morepen.com

Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA Tel.: +91 1795 266401-03, 244590, Fax: +91 1795 244591, E-mail: [email protected]